Fielding J W, Roginski C, Ellis D J, Jones B G, Powell J, Waterhouse J A, Brookes V S
Br J Surg. 1984 Sep;71(9):677-80. doi: 10.1002/bjs.1800710910.
13 175 patients with gastric carcinomas have been staged with reference to the TNM staging system. This has confirmed the poor overall prognosis (5.5 per cent and 3.8 per cent age-adjusted survival rates at 5 and 10 years respectively). However, it has demonstrated the significant survival associated with the treatment of Stage I disease (70.0 per cent at 5 years and 63.2 per cent at 10 years). This study demonstrates that 72.9 per cent of cases are unresected and that interpretation of resectability rates must be related to the population base of the study.
13175例胃癌患者已根据TNM分期系统进行了分期。这证实了总体预后较差（5年和10年的年龄调整生存率分别为5.5%和3.8%）。然而，它显示了与I期疾病治疗相关的显著生存率（5年时为70.0%，10年时为63.2%）。这项研究表明，72.9%的病例未接受手术切除，并且对可切除率的解释必须与研究的人群基础相关。
